Clincosm LogoSign in Get a demo

Cancer

Showing NaN - NaN of 100
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer, Tumors, Tumor Trial in Worldwide (BMS-986226, Nivolumab, Ipilimumab)

Completed
  • Cancer
  • +3 more
  • Boston, Massachusetts
  • +12 more
Mar 11, 2022

Cancer Trial in Chicago, Philadelphia, Memphis (Remote Telegenetic Counseling by Phone, Remote Telegenetic Counseling by

Recruiting
  • Cancer
  • Remote Telegenetic Counseling by Phone
  • +2 more
  • Chicago, Illinois
  • +2 more
Mar 10, 2022

Cancer, Lung Cancer, Gastro-intestinal Trial in Philadelphia (PRO questionnaire, Step monitoring, Active nudge text feedback)

Completed
  • Cancer
  • +2 more
  • PRO questionnaire
  • +3 more
  • Philadelphia, Pennsylvania
    Perelman Center for Advanced Medicine (PCAM)
Feb 16, 2022

Cancer Trial in United States (mAb RAV12)

Completed
  • Cancer
  • monoclonal antibody RAV12
  • Santa Monica, California
  • +4 more
Feb 4, 2022

HER2-positive, Adenocarcinoma, Bile Duct Cancer Trial in United States (CT-0508)

Recruiting
  • HER2-positive
  • +30 more
  • CT-0508
  • Duarte, California
  • +4 more
Feb 1, 2022

Tumors, Cancer, Caregiver Trial in Philadelphia

Recruiting
  • Neoplasms
  • +2 more
    • Philadelphia, Pennsylvania
      Cancer Support Community Research & Training Institute
    Jan 30, 2022

    Autoimmunity After Checkpoint Blockade

    Recruiting
    • Autoimmunity
    • +3 more
      • Philadelphia, Pennsylvania
        University of Pennsylvania - Abramson Cancer Center
      Nov 29, 2021

      Cancer, Non Small Cell Lung Cancer Metastatic, Metastatic Melanoma Trial in Spain, United States (APX005M, Nivolumab)

      Completed
      • Cancer
      • +4 more
      • Tucson, Arizona
      • +22 more
      Dec 3, 2021

      Cancer Trial in Philadelphia (Intervention)

      Recruiting
      • Cancer
      • Intervention
      • Philadelphia, Pennsylvania
        Albert Einstein Healthcare Network
      Dec 7, 2021

      Cancer Trial in Worldwide (Dabrafenib, Trametinib, Panitumumab)

      Completed
      Has Results
      • Cancer
      • Scottsdale, Arizona
      • +19 more
      Sep 30, 2021

      Gastrointestinal Stromal Tumors, Sdh, GIST Trial in United States (Temozolomide)

      Recruiting
      • Gastrointestinal Stromal Tumors
      • +3 more
      • La Jolla, California
      • +4 more
      Aug 17, 2021

      Cancer Trial in Worldwide (Trametinib, Dabrafenib)

      Completed
      Has Results
      • Cancer
      • Phoenix, Arizona
      • +15 more
      Jun 21, 2021

      Aspirin in Reducing Events in the Elderly

      Active, not recruiting
      • Functional Disability
      • +6 more
      • 100 mg enteric-coated aspirin
      • Placebo
      • Birmingham, Alabama
      • +46 more
      Apr 2, 2021

      Cancer Trial in United States (Aspirin, Placebo)

      Active, not recruiting
      • Cancer
      • Birmingham, Alabama
      • +39 more
      Apr 2, 2021

      Cancer Trial in Worldwide (Leucovorin, Fluorouracil - bolus, Bevacizumab)

      Terminated
      Has Results
      • Cancer
      • Chandler, Arizona
      • +64 more
      Jan 20, 2021

      Renal Cell Carcinoma (RCC), Cancer Trial in Worldwide (pazopanib, )

      Completed
      Has Results
      • Renal Cell Carcinoma (RCC)
      • Cancer
      • Jonesboro, Arkansas
      • +311 more
      Oct 29, 2020

      Breast Cancer, Cancer Trial in Worldwide (Venetoclax, Capecitabine)

      Terminated
      • Breast Cancer
      • Cancer
      • Joliet, Illinois
      • +17 more
      Oct 28, 2020

      This Study Will Focus on Recruitment Strategies and Attitudes Towards Research Among Patients Considering Participation in 2

      Completed
      • This Study Will Focus on Recruitment Strategies and Attitudes Towards Research Among Patients Considering Participation in 2 Parent Randomized Controlled Trials
      • +2 more
      • High-level recruitment strategy consent form
      • Mid-level recruitment strategy consent form
      • Chicago, Illinois
      • +6 more
      Oct 21, 2020

      (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products

      Terminated
      • ALS
      • +17 more
      • Registry
      • PK microsampling of blood
      • Philadelphia, Pennsylvania
        Children's Hospital of Philadelphia
      Jul 28, 2020

      Cancer Trial in Philadelphia (recombinant adenovirus-hIFN-beta)

      Completed
      • Cancer
      • recombinant adenovirus-hIFN-beta
      • Philadelphia, Pennsylvania
        Abramson Cancer Center of the University of Pennsylvania
      May 12, 2020

      Cancer, NSCLC, Melanoma Trial in Duarte, Cleveland, Philadelphia (APX005M)

      Completed
      • Cancer
      • +5 more
      • Duarte, California
      • +2 more
      Apr 27, 2020

      Synovial Sarcoma, Cancer, Soft Tissue Sarcoma Trial in Canada, United States (LV305, G305, LV305-matching )

      Terminated
      Has Results
      • Synovial Sarcoma
      • +4 more
      • LV305
      • +3 more
      • Scottsdale, Arizona
      • +28 more
      Apr 3, 2020

      Cancer Trial in Philadelphia (Camp Discovery)

      Completed
      • Cancer
      • Camp Discovery
      • Philadelphia, Pennsylvania
        Community in Philadelphia
      Apr 13, 2020

      Cancer, Hematologic Malignancies, Multiple Myeloma Trial in Worldwide (Denosumab, Zoledronic acid, Placebo to Denosumab)

      Completed
      Has Results
      • Cancer
      • +5 more
      • Tucson, Arizona
      • +308 more
      Mar 19, 2020

      Cancer Trial in Philadelphia (Default initiation)

      Completed
      Has Results
      • Cancer
      • Default initiation
      • Philadelphia, Pennsylvania
        University of Pennsylvania Health System
      Nov 20, 2019